Background The clinical use of cyclosporine (CsA) is limited by its nephrot
oxicity. Apoptosis, perhaps instigated by increased nitric oxide synthase (
NOS) activity,may play a role in such toxicity.
Methods. Human mesangial cells, human tubular cells, human umbilical vein e
ndothelial cells, or murine endothelial cells were cultured with CsA at fin
al concentrations of 0 to 1000 ng/mL for 4 to 24 hours. As inhibitors of ap
optosis, 0.01 mol/L L-nitromethylarginine (L-NAME) or 1 mu g/mL cycloheximi
de (CHX) was added, whereas 0.01 mol/L sodium nitroprusside (as a nitric ox
ide donor) was used as a positive control. Apoptosis was assessed by using
TUNEL method and by DNA fragmentation by electrophoresis. In addition, NOS
enzymatic activity, Northern blots for inducible NOS (iNOS) mRNA, and immun
ohistochemically demonstrable iNOS protein were evaluated.
Results. Within 12 to 24 hours, CsA significantly increased the fraction (8
to 35%) of apoptotic cells in each cell line, according to the dose. Fragm
entation of DNA confirmed apoptosis. L-NAME and CHX inhibited the phenomeno
n, whereas sodium nitroprusside enhanced it. Each cell line significantly i
ncreased NOS activity in response to CsA, an effect blunted by L-NAME and C
HX. Neither inhibitor modified the increased iNOS mRNA expression elicited
by CsA. Positive staining for both iNOS and p53 proteins was observed in al
l cell lines incubated with CsA that were inhibited by CHX; L-NAME inhibite
d only p53 staining.
Conclusions. CsA induces apoptosis in various renal cell lines, and this ef
fect is mediated by the induction of iNOS via p53. These effects may contri
bute to the acellular fibrosis characteristic of late CsA nephrotoxicity.